Methods of treating dermatological disorders and inducing interferon biosynthesis with shorter durations of imiquimod therapy
AssigneeMedicis Pharmaceutical Corporation
InventorJefferson J. Gregory
Life of this patent
Estimating the term…
Abstract
Pharmaceutical formulations and methods for the topical and/or transdermal delivery of imiquimod, including creams, ointments and pressure-sensitive adhesive compositions to treat dermatological disorders, namelyl, viral infections, such as Type I or Type II Herpes simplex infections and genital and perianal warts, actinic deratosis and superficial basal cell carcinoma, and to induce interferon biosynthesis to achieve an antiviral effect, with shorter durations of therapy, than currently approved for imiquimod by the Food & Drug Administration (“FDA”).
Claims15
A method for treating genital or perianal warts in a subject, the method comprising:
- applying an imiquimod pharmaceutical cream formulated with 3.75% by weight imiquimod to the warts, once per day, each day, for up to about 8 consecutive weeks or until clearance is observed, whichever occurs earlier, to treat the warts.
Dependencies are inferred from the claim text.